CVE-2026-21997
- State
- Published
- Severity
- 8.5 High
- Published
- Apr 21, 2026
- Updated
- Apr 22, 2026
- Reserved
- Jan 5, 2026
Description
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Scores
| CVSS | Score | Vector | Source |
|---|---|---|---|
| 3.1 | 8.5 High | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N | oracle |
Weaknesses
- CWE-284 Improper Access Control
Affected Products
| Product | Versions |
|---|---|
Oracle Life Sciences Empirica SignalOracle Corporation |
|
References
- Oracle Advisoryvendor-advisory
Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.